Journal Article DKFZ-2022-01289

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β=2Gy overestimates the RBE.

 ;  ;  ;  ;  ;  ;  ;

2022
Elsevier Science Amsterdam [u.a.]

Radiotherapy and oncology 173, 223-230 () [10.1016/j.radonc.2022.06.006]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: To analyze the long-term effectiveness of carbon ions relative to protons in the prospective randomized controlled ion prostate irradiation (IPI) trial.Effectiveness via PSA assessment in a randomized study on prostate irradiation with 20x3.3Gy(RBE) protons versus carbon ions was analyzed in 92 patients. Proton RBE was based on a fixed RBE of 1.1 while the local effect model (LEM) I and an α/β=2Gy was used for carbon ions. The dose in the prostate was recalculated based on the delivered treatment plan using LEM I and LEM IV and different α/β values.Five-year overall and progression free survival was 98% and 85% with protons and 91% and 50% with carbon ions, respectively, with the latter being unexpectedly low compared to Japanese carbon ion data and rather corresponding to a photon dose <72 Gy in 2 Gy fractions. According to LEM I and the applied α/β-value of 2Gy, the applied carbon ion dose in 2 Gy(RBE) fractions (EQD2) was 87.46 Gy(RBE). Recalculations confirmed a strong dependence of RBE-weighted dose on the α/β ratio as well as on the RBE-model.The data demonstrate a significant lower effectiveness of the calculated RBE-weighted dose in the carbon ion as compared to the proton arm. LEM I and an α/β = 2 Gy overestimates the RBE for carbon ions in prostate cancer treatment. Adjusting the biological dose calculation by using LEM I with α/β=4 Gy could be a pragmatic way to safely escalate dose in carbon ion radiotherapy for prostate cancer.

Keyword(s): Carbon ion and proton radiotherapy ; Local effect model (LEM) ; Prostate cancer ; Relative biological effectiveness (RBE) ; α/β ratio

Classification:

Note: 2022 Jun 14;173:223-230

Contributing Institute(s):
  1. E040 Med. Physik in der Strahlentherapie (E040)
  2. E050 KKE Strahlentherapie (E050)
  3. DKTK HD zentral (HD01)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2022
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > E040
Public records
Publications database

 Record created 2022-06-20, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)